Blog

WHO-GMP Certification for Indian Generic Medicines: A 2026 Buyer’s Complete Guide

  • Post category:Knowledge

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

3. Product-Specific Documentation

For each product you intend to buy, request:

  • Batch manufacturing record (BMR) for the specific batch being supplied — this shows the actual production parameters, raw material lot numbers, and quality test results for that batch.
  • Certificate of Analysis (CoA) — the laboratory test report confirming that the finished product meets specified quality standards (assay, dissolution, impurities, microbial limits, etc.).
  • Stability data — evidence that the product maintains its quality throughout its shelf life under defined storage conditions.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

2. Manufacturing License

WHO-GMP certification is a quality system assessment; the manufacturing license is the legal authorization to produce drugs. Request the manufacturer’s current manufacturing license issued by the state drug control authority. In India, this is typically issued by the state licensing authority (SLA) where the facility is located.

3. Product-Specific Documentation

For each product you intend to buy, request:

  • Batch manufacturing record (BMR) for the specific batch being supplied — this shows the actual production parameters, raw material lot numbers, and quality test results for that batch.
  • Certificate of Analysis (CoA) — the laboratory test report confirming that the finished product meets specified quality standards (assay, dissolution, impurities, microbial limits, etc.).
  • Stability data — evidence that the product maintains its quality throughout its shelf life under defined storage conditions.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

1. The WHO-GMP Certificate Itself

Ask the manufacturer or distributor to share a copy of their current WHO-GMP certificate. Verify these details on the document:

  • Issuing authority: Should be CDSCO or an authorized state drug control authority.
  • Facility name and address: Must match the supplier you are dealing with — not a different site.
  • Expiry date: WHO-GMP certificates are time-limited. An expired certificate means the facility has not undergone re-inspection.
  • Scope: Some certificates cover specific manufacturing lines or product categories, not the entire facility. Verify that the product you are buying falls within the certified scope.

2. Manufacturing License

WHO-GMP certification is a quality system assessment; the manufacturing license is the legal authorization to produce drugs. Request the manufacturer’s current manufacturing license issued by the state drug control authority. In India, this is typically issued by the state licensing authority (SLA) where the facility is located.

3. Product-Specific Documentation

For each product you intend to buy, request:

  • Batch manufacturing record (BMR) for the specific batch being supplied — this shows the actual production parameters, raw material lot numbers, and quality test results for that batch.
  • Certificate of Analysis (CoA) — the laboratory test report confirming that the finished product meets specified quality standards (assay, dissolution, impurities, microbial limits, etc.).
  • Stability data — evidence that the product maintains its quality throughout its shelf life under defined storage conditions.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

🔍 What Buyers Should Ask For

When evaluating an Indian generic medicine supplier, here are the specific documents and verifications you should request:

1. The WHO-GMP Certificate Itself

Ask the manufacturer or distributor to share a copy of their current WHO-GMP certificate. Verify these details on the document:

  • Issuing authority: Should be CDSCO or an authorized state drug control authority.
  • Facility name and address: Must match the supplier you are dealing with — not a different site.
  • Expiry date: WHO-GMP certificates are time-limited. An expired certificate means the facility has not undergone re-inspection.
  • Scope: Some certificates cover specific manufacturing lines or product categories, not the entire facility. Verify that the product you are buying falls within the certified scope.

2. Manufacturing License

WHO-GMP certification is a quality system assessment; the manufacturing license is the legal authorization to produce drugs. Request the manufacturer’s current manufacturing license issued by the state drug control authority. In India, this is typically issued by the state licensing authority (SLA) where the facility is located.

3. Product-Specific Documentation

For each product you intend to buy, request:

  • Batch manufacturing record (BMR) for the specific batch being supplied — this shows the actual production parameters, raw material lot numbers, and quality test results for that batch.
  • Certificate of Analysis (CoA) — the laboratory test report confirming that the finished product meets specified quality standards (assay, dissolution, impurities, microbial limits, etc.).
  • Stability data — evidence that the product maintains its quality throughout its shelf life under defined storage conditions.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

📝 The Regulatory Framework: CDSCO, DCGI, and WHO-GMP in India

In India, WHO-GMP certification is issued through the Central Drugs Standard Control Organization (CDSCO), headed by the Drugs Controller General of India (DCGI). The certification process is governed by the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, which mandate that manufacturers of certain drug categories obtain a WHO-GMP certificate before they can export to regulated markets.

The CDSCO’s Quality Council of India (QCI) and the National Pharmaceutical Quality Monitoring Committee (NPQMC) provide additional oversight. The practical certification pathway works like this:

  • Step 1 — Self-assessment: The manufacturer prepares its quality management system to align with WHO-GMP guidelines, covering everything from premises and equipment to personnel and documentation.
  • Step 2 — Pre-inspection audit: Many manufacturers conduct internal audits or hire third-party consultants to identify gaps before the official inspection.
  • Step 3 — CDSCO inspection: A CDSCO inspector visits the facility, reviews batch records, tests quality control samples, interviews staff, and audits the documentation system.
  • Step 4 — Certification or observations: If compliant, the CDSCO issues a WHO-GMP certificate valid for a defined period (typically one to three years, subject to renewal inspections). If non-compliant, the inspector issues observations that the manufacturer must address before certification.
  • Step 5 — Surveillance inspections: Periodic re-inspections ensure the facility maintains standards after initial certification.

🔍 What Buyers Should Ask For

When evaluating an Indian generic medicine supplier, here are the specific documents and verifications you should request:

1. The WHO-GMP Certificate Itself

Ask the manufacturer or distributor to share a copy of their current WHO-GMP certificate. Verify these details on the document:

  • Issuing authority: Should be CDSCO or an authorized state drug control authority.
  • Facility name and address: Must match the supplier you are dealing with — not a different site.
  • Expiry date: WHO-GMP certificates are time-limited. An expired certificate means the facility has not undergone re-inspection.
  • Scope: Some certificates cover specific manufacturing lines or product categories, not the entire facility. Verify that the product you are buying falls within the certified scope.

2. Manufacturing License

WHO-GMP certification is a quality system assessment; the manufacturing license is the legal authorization to produce drugs. Request the manufacturer’s current manufacturing license issued by the state drug control authority. In India, this is typically issued by the state licensing authority (SLA) where the facility is located.

3. Product-Specific Documentation

For each product you intend to buy, request:

  • Batch manufacturing record (BMR) for the specific batch being supplied — this shows the actual production parameters, raw material lot numbers, and quality test results for that batch.
  • Certificate of Analysis (CoA) — the laboratory test report confirming that the finished product meets specified quality standards (assay, dissolution, impurities, microbial limits, etc.).
  • Stability data — evidence that the product maintains its quality throughout its shelf life under defined storage conditions.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

🏆 What Is WHO-GMP and Why Does It Matter?

WHO-GMP is a set of internationally recognized manufacturing quality standards developed by the World Health Organization. Unlike a drug approval — which evaluates whether a specific medicine is safe and effective for a specific indication — WHO-GMP evaluates the manufacturing facility itself: its hygiene practices, quality control laboratories, documentation systems, personnel training, equipment calibration, and traceability procedures.

For buyers of Indian generic medicines, a WHO-GMP certificate sends three clear signals:

  • The facility operates under controlled, documented conditions — not ad-hoc or informal production.
  • The manufacturer has been independently assessed — typically by India’s Central Drugs Standard Control Organization (CDSCO) or an authorized inspectorate.
  • The product has a higher probability of consistent quality across batches, because the manufacturing environment is regulated.

📝 The Regulatory Framework: CDSCO, DCGI, and WHO-GMP in India

In India, WHO-GMP certification is issued through the Central Drugs Standard Control Organization (CDSCO), headed by the Drugs Controller General of India (DCGI). The certification process is governed by the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, which mandate that manufacturers of certain drug categories obtain a WHO-GMP certificate before they can export to regulated markets.

The CDSCO’s Quality Council of India (QCI) and the National Pharmaceutical Quality Monitoring Committee (NPQMC) provide additional oversight. The practical certification pathway works like this:

  • Step 1 — Self-assessment: The manufacturer prepares its quality management system to align with WHO-GMP guidelines, covering everything from premises and equipment to personnel and documentation.
  • Step 2 — Pre-inspection audit: Many manufacturers conduct internal audits or hire third-party consultants to identify gaps before the official inspection.
  • Step 3 — CDSCO inspection: A CDSCO inspector visits the facility, reviews batch records, tests quality control samples, interviews staff, and audits the documentation system.
  • Step 4 — Certification or observations: If compliant, the CDSCO issues a WHO-GMP certificate valid for a defined period (typically one to three years, subject to renewal inspections). If non-compliant, the inspector issues observations that the manufacturer must address before certification.
  • Step 5 — Surveillance inspections: Periodic re-inspections ensure the facility maintains standards after initial certification.

🔍 What Buyers Should Ask For

When evaluating an Indian generic medicine supplier, here are the specific documents and verifications you should request:

1. The WHO-GMP Certificate Itself

Ask the manufacturer or distributor to share a copy of their current WHO-GMP certificate. Verify these details on the document:

  • Issuing authority: Should be CDSCO or an authorized state drug control authority.
  • Facility name and address: Must match the supplier you are dealing with — not a different site.
  • Expiry date: WHO-GMP certificates are time-limited. An expired certificate means the facility has not undergone re-inspection.
  • Scope: Some certificates cover specific manufacturing lines or product categories, not the entire facility. Verify that the product you are buying falls within the certified scope.

2. Manufacturing License

WHO-GMP certification is a quality system assessment; the manufacturing license is the legal authorization to produce drugs. Request the manufacturer’s current manufacturing license issued by the state drug control authority. In India, this is typically issued by the state licensing authority (SLA) where the facility is located.

3. Product-Specific Documentation

For each product you intend to buy, request:

  • Batch manufacturing record (BMR) for the specific batch being supplied — this shows the actual production parameters, raw material lot numbers, and quality test results for that batch.
  • Certificate of Analysis (CoA) — the laboratory test report confirming that the finished product meets specified quality standards (assay, dissolution, impurities, microbial limits, etc.).
  • Stability data — evidence that the product maintains its quality throughout its shelf life under defined storage conditions.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

When you are sourcing generic medicines from India — whether for a hospital formulary, a government tender, or personal use — the WHO-GMP (World Health Organization Good Manufacturing Practice) certification is the single most important quality signal you can verify before placing an order. But what exactly does this certificate mean, how do you check it, and what are its limits? This guide walks you through everything a buyer needs to know in 2026.

🏆 What Is WHO-GMP and Why Does It Matter?

WHO-GMP is a set of internationally recognized manufacturing quality standards developed by the World Health Organization. Unlike a drug approval — which evaluates whether a specific medicine is safe and effective for a specific indication — WHO-GMP evaluates the manufacturing facility itself: its hygiene practices, quality control laboratories, documentation systems, personnel training, equipment calibration, and traceability procedures.

For buyers of Indian generic medicines, a WHO-GMP certificate sends three clear signals:

  • The facility operates under controlled, documented conditions — not ad-hoc or informal production.
  • The manufacturer has been independently assessed — typically by India’s Central Drugs Standard Control Organization (CDSCO) or an authorized inspectorate.
  • The product has a higher probability of consistent quality across batches, because the manufacturing environment is regulated.

📝 The Regulatory Framework: CDSCO, DCGI, and WHO-GMP in India

In India, WHO-GMP certification is issued through the Central Drugs Standard Control Organization (CDSCO), headed by the Drugs Controller General of India (DCGI). The certification process is governed by the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, which mandate that manufacturers of certain drug categories obtain a WHO-GMP certificate before they can export to regulated markets.

The CDSCO’s Quality Council of India (QCI) and the National Pharmaceutical Quality Monitoring Committee (NPQMC) provide additional oversight. The practical certification pathway works like this:

  • Step 1 — Self-assessment: The manufacturer prepares its quality management system to align with WHO-GMP guidelines, covering everything from premises and equipment to personnel and documentation.
  • Step 2 — Pre-inspection audit: Many manufacturers conduct internal audits or hire third-party consultants to identify gaps before the official inspection.
  • Step 3 — CDSCO inspection: A CDSCO inspector visits the facility, reviews batch records, tests quality control samples, interviews staff, and audits the documentation system.
  • Step 4 — Certification or observations: If compliant, the CDSCO issues a WHO-GMP certificate valid for a defined period (typically one to three years, subject to renewal inspections). If non-compliant, the inspector issues observations that the manufacturer must address before certification.
  • Step 5 — Surveillance inspections: Periodic re-inspections ensure the facility maintains standards after initial certification.

🔍 What Buyers Should Ask For

When evaluating an Indian generic medicine supplier, here are the specific documents and verifications you should request:

1. The WHO-GMP Certificate Itself

Ask the manufacturer or distributor to share a copy of their current WHO-GMP certificate. Verify these details on the document:

  • Issuing authority: Should be CDSCO or an authorized state drug control authority.
  • Facility name and address: Must match the supplier you are dealing with — not a different site.
  • Expiry date: WHO-GMP certificates are time-limited. An expired certificate means the facility has not undergone re-inspection.
  • Scope: Some certificates cover specific manufacturing lines or product categories, not the entire facility. Verify that the product you are buying falls within the certified scope.

2. Manufacturing License

WHO-GMP certification is a quality system assessment; the manufacturing license is the legal authorization to produce drugs. Request the manufacturer’s current manufacturing license issued by the state drug control authority. In India, this is typically issued by the state licensing authority (SLA) where the facility is located.

3. Product-Specific Documentation

For each product you intend to buy, request:

  • Batch manufacturing record (BMR) for the specific batch being supplied — this shows the actual production parameters, raw material lot numbers, and quality test results for that batch.
  • Certificate of Analysis (CoA) — the laboratory test report confirming that the finished product meets specified quality standards (assay, dissolution, impurities, microbial limits, etc.).
  • Stability data — evidence that the product maintains its quality throughout its shelf life under defined storage conditions.

🔎 How to Verify a WHO-GMP Certificate Online

CDSCO has been moving toward digital verification of manufacturing certifications. Buyers can take these practical steps to verify a supplier’s claims:

  • Check CDSCO’s online portals — The CDSCO and state drug control authorities maintain databases of licensed manufacturers and WHO-GMP certified facilities. If a certificate number is provided, it may be verifiable through these portals.
  • Cross-reference the manufacturer name — Search for the manufacturer on the CDSCO drug license database and the pharmacist licensing portal to confirm the entity exists and holds valid authorizations.
  • Look for the certificate number and issue date — A legitimate WHO-GMP certificate contains a unique certificate number and an issue date. A document without these identifiers should be treated with caution.
  • Contact CDSCO directly — For high-value procurement, buyers can write to the CDSCO’s Ayush Bhawan office in New Delhi to verify a specific certificate. This is especially prudent for bulk hospital or government procurement.

🔐 The Limits of WHO-GMP: What It Does NOT Guarantee

A WHO-GMP certificate is an important quality signal, but it is not a guarantee of everything a buyer might assume. Here are the genuine limitations buyers should understand:

  • It does not replace drug approval. WHO-GMP certifies the manufacturing process, not the drug’s efficacy or safety for a specific indication. A WHO-GMP certified facility can still produce a substandard or adulterated product if quality control fails at the batch level — which is why batch-specific CoAs are essential.
  • It is not a global market authorization. WHO-GMP certification from CDSCO does not automatically authorize export to any specific country. Export to the US requires FDA approval, to the EU requires EMA or national competent authority approval, and each regulated market has its own requirements.
  • It covers the facility, not every product. A WHO-GMP certificate may cover specific manufacturing lines. A facility can be certified for one product category while producing another product without certification. Always confirm the product you are buying is within the certified scope.
  • Surveillance gaps exist. Re-inspection intervals vary, and a facility’s quality system can deteriorate between surveillance visits. Ongoing batch-level quality documentation is the best safeguard against this gap.

📝 Practical Buyer’s Checklist

Use this checklist when evaluating any Indian generic medicine supplier:

  • ☐ Request a copy of the supplier’s current WHO-GMP certificate — verify the issuing authority, facility name, expiry date, and scope.
  • ☐ Request the supplier’s current manufacturing license from the state drug control authority.
  • ☐ For each product, request a batch-specific Certificate of Analysis (CoA).
  • ☐ Cross-reference the manufacturer’s name on CDSCO and state drug control databases.
  • ☐ Confirm the specific product falls within the WHO-GMP certificate’s certified scope.
  • ☐ For regulated-market exports (US, EU, etc.), verify the product holds the relevant market authorization — FDA approval, EU marketing authorization, etc. — in addition to WHO-GMP.
  • ☐ Ask whether the supplier participates in India’s National Pharmacovigilance Programme (PvPI) for post-market safety reporting.
  • ☐ For high-value or bulk procurement, consider an independent third-party audit of the manufacturing facility.

🏞 Finding Reliable Sources

Sourcing quality-assured generic medicines requires both documentation verification and trusted sourcing channels. Buyers should prioritize suppliers who can readily provide WHO-GMP certificates, manufacturing licenses, and batch-level CoAs without hesitation. Reluctance to share quality documentation is itself a red flag.

For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which includes distributors who adhere to quality and transparency standards.

Sources: World Health Organization (WHO) Good Manufacturing Practice guidelines; Central Drugs Standard Control Organization (CDSCO), Government of India — Drugs and Cosmetics Act, 1940 and Rules, 1945; National Pharmaceutical Quality Monitoring Committee (NPQMC) framework; Drugs Controller General of India (DCGI) manufacturing certification procedures. Regulatory information as of 2026.

For more information, contact IMSDA at contact@indiamedicine.org.

Tags: , , ,